gdc
Prostate Cancer

Drugs for Prostate Cancer

Here are the financial support services available to patients receiving treatment for Prostate Cancer.

Axumin (fluciclovine F18 Injection)

Drug company: Blue Earth Diagnostics
855-495-9200

Axumin is a radioactive diagnostic agent used for positron emission tomography imaging in men with suspected prostate cancer recurrence.

(Blue Earth Diagnostics does not currently offer any financial assistance for Axumin.)

Emcyt (estramustine phosphate sodium capsules)

Drug company: Pfizer
844-989-7284

Emcyt capsules are used as palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate.

Pfizer RxPathways offers 2 financial assistance programs for patients using Emcyt:

Pfizer Patient Assistance Program

Patients who are prescribed a Pfizer specialty medicine, such as Emcyt, and meet certain income limits, but do not have sufficient prescription coverage to pay for the medicine can use this program to receive free medicine through their doctor’s office, at home, or possibly through their pharmacy.

Pfizer Savings Program

Through this program, uninsured patients, regardless of income, will see an estimated savings of 36% to 75% on their medication costs when purchased at a participating retail pharmacy.

Jevtana (cabazitaxel)

Drug company: Sanofi Genzyme
888-847-4877

Jevtana is a microtubule inhibitor used, in combination with prednisone, for the treatment of patients with hormone- refractory metastatic prostate cancer, after treatment with a docetaxel-based regimen.

The Sanofi Patient Connection offers 1 financial assistance program for patients using Jevtana:

Sanofi Patient Assistance Connection

Patients who are uninsured or whose insurance does not cover Jevtana can apply for financial assistance through this program. Eligible patients must have an annual household income of no more than 500% of the current poverty level. Patients with Medicare Part D can apply if they are not eligible for Low Income Subsidy and have out-of-pocket drug costs that equal 5% or more of their annual income.

Premarin (conjugated estrogens tablets)

Drug company: Pfizer
844-989-7284

Premarin is a mixture of estrogens used as palliative treatment of patients with advanced androgen-dependent carcinoma of the prostate.

Pfizer offers 3 financial assistance programs for patients using Premarin:

Premarin Savings Card

With this savings card, patients who are not fully reimbursed for Premarin can pay as little as $15, with a savings of up to $55 per prescription fill. The card is limited to 12 offers and a maximum savings of $660 per calendar year.

Pfizer Patient Assistance Program

Patients who are prescribed a Pfizer specialty medicine, such as Premarin, and meet certain income limits, but do not have sufficient prescription coverage to pay for the medicine can use this program to receive free medicine through their doctor’s office, at home, or possibly through their pharmacy.

Free Medicine Through Health Centers and Hospitals

Uninsured patients may be eligible to receive Premarin tablets for free at select health centers and hospitals nationwide. Drug availability varies by institution and eligibility.

Provenge (sipuleucel-T)

Drug company: Dendreon
877-336-3736

Provenge is an autologous cellular immunotherapy used for the treatment of patients with metastatic castration-resistant (hormone-refractory) prostate cancer.

Dendreon offers 3 financial assistance programs for patients using Provenge:

PROvide Commercial Co-pay Program

This program supports eligible, insured patients by covering any combination of cost (copays, coinsurance, or deductibles) to a maximum of $6,000 over 3 Provenge treatments.

Co-pay Assistance for Patients with Medicare

This program helps eligible patients with Medicare pay for copays, coinsurance, and deductibles.

Provenge Uninsured Patient Program

Patients who are uninsured and who have an adjusted gross income of $150,000 a year or less may be able to get Provenge at no cost through this program.

Trelstar (triptorelin pamoate) for injectable suspension

Drug company: Allergan
844-424-6727

Trelstar is a gonadotropin-releasing hormone agonist used as palliative treatment of advanced prostate cancer.

Allergan offers 1 financial assistance program for patients using Trelstar:

Allergan Patient Assistance Program

Patients who cannot afford the cost of Trelstar and meet other eligibility requirements may qualify for free medication. Eligible applicants will be enrolled for 12 months and a 90-day supply of medication will be immediately shipped to the physician. Medicare Part D applicants must have been denied Low Income Subsidy and will only be enrolled until the end of the calendar year.

Xofigo (radium Ra 223 dichloride) injection

Drug company: Bayer
855-696-3446

Xofigo is an alpha particle–emitting radioactive therapeutic agent used for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease.

Bayer offers 2 financial assistance programs for patients using Xofigo:

Xofigo Access Services $0 Copay

This program provides privately insured patients with a Commercial Copay Assistance ID card so that the copay for Xofigo is $0.

Xofigo Access Services Financial Assistance Program

This program provides Xofigo free of charge for eligible patients who are uninsured or are without coverage for Xofigo. Applicants must meet certain financial criteria.

Xtandi (enzalutamide)

Drug company: Astellas
855-898-2634

Xtandi is an androgen receptor inhibitor used for the treatment of patients with metastatic castration-resistant prostate cancer.

Astellas offers 3 financial assistance programs for patients using Xtandi:

Xtandi Patient Savings Program

This program allows eligible, privately insured patients to pay no more than $20 per prescription of Xtandi, with a benefit of up to $5,000 per prescription and $25,000 annually.

Xtandi Quick Start+ Program

Eligible, new patients awaiting coverage determination will be provided a free 14-day supply of Xtandi.

Astellas Patient Assistance Program

Patients who do not have prescription coverage for Xtandi may receive their medication at no cost through this program. Applicants must have an annual household income of less than $100,000.

Zoladex (goserelin acetate implant)

Drug company: AstraZeneca
800-292-6363

Zoladex is a gonadotropin-releasing hormone agonist used, in combination with flutamide, for the treatment of patients with locally confined carcinoma of the prostate, and as a palliative treatment of advanced carcinoma of the prostate.

AstraZeneca offers 1 financial assistance program for patients using Zoladex:

AZ&Me Prescription Savings Programs

Qualifying patients will receive free medicine through this group of programs. Eligible patients must meet certain income limits, and have no prescription drug coverage or participate in Medicare Part D. Patients who do not meet these requirements but have recently had a change in their financial circumstances may still qualify.

Zytiga (abiraterone acetate)

Drug company: Janssen Biotech
855-998-4421

Zytiga is a CYP17 inhibitor used, in combination with prednisone, for the treatment of patients with metastatic castration-resistant prostate cancer.

Janssen offers 2 financial assistance programs for patients using Zytiga:

Janssen CarePath Savings Program

With this card, privately insured patients will pay no more than $10 monthly for their medicine, with a $12,000 maximum benefit per calendar year.

Johnson & Johnson Patient Assistance Foundation

This program provides Zytiga free of charge for up to 12 months to patients who meet certain financial limits and are uninsured, underinsured, or enrolled in Medicare Part D.

Table. Drugs Prescribed for Prostate Cancer

  • Drug name (generic name)
  • Drug company
  • Indication
  • Patient support services
    Drug name (generic name)
  • Axumin (fluciclovine F18 Injection)
  • Drug company
  • Blue Earth Diagnostics
  • Indication
  • PET imaging for suspected prostate cancer recurrence
  • Patient support services
  • (No specific program)


    Drug name (generic name)
  • Jevtana (cabazitaxel)
  • Drug company
  • Sanofi Genzyme
  • Indication
  • Hormone-refractory metastatic prostate cancer, in combination with prednisone, after a docetaxel-based regimen
  • Patient support services
  • Sanofi Patient Assistance Connection
    888-847-4877



    Drug name (generic name)
  • Trelstar (triptorelin pamoate) for injectable suspension
  • Drug company
  • Allergan
  • Indication
  • Advanced prostate cancer
  • Patient support services
  • Allergan Patient Assistance Program
    844-424-6727



    Drug name (generic name)
  • Zoladex (goserelin acetate implant)
  • Drug company
  • AstraZeneca
  • Indication
  • Locally confined carcinoma of the prostate, in combination with flutamide

    Advanced carcinoma of the prostate
  • Patient support services
  • AZ&Me Prescription Savings Programs
    800-292-6363


Last modified: April 16, 2018

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country